title: Methylation of the RASSFIA promoter in breast cancer.
abstract: Tumor suppressor genes are the key targets of hypermethylation in breast cancer and may therefore lead to malignancy by deregulation of cell growth and division. Our previous pilot study with pairs of malignant and normal breast tissues identified a correlation between RASSFIA gene methylation and breast cancer. To determine the relationship between RASSFIA methylation and breast cancer, we conducted a larger study. We took samples from 108 patients with breast cancer, 28 patients with benign breast tumors, and 33 subjects with normal breast tissues at the Second Affiliated Hospital of Nanjing Medical University at Wuxi between July 2013 and September 2015. We used the samples to investigate methylation levels of the RASSF1A gene for associations with breast cancer. Quantitative real-time polymerase chain reaction (PCR) and methylation-specific PCR were used to investigate the levels of RASSF1A mRNA expression and RASSF1A methylation, respectively. RASSFIA was not expressed in 22 of the 108 breast cancer tissue samples (20.37%), and there was no statistically significant difference (P > 0.05); however, RASSFIA expression was significantly lower than that in the normal breast tissue samples (P < 0.05). Moreover, the methylation rate of the RASSFIA gene promoter was significantly higher in the breast cancer tissues (64.81%) than in the normal breast tissues (18.18%) and benign breast tumors (17.86%) (P < 0.05). High methylation of the RASSF1A gene promoter was an important reason for its downregulation, and the gene played a critical regulated role in the incidence and development of breast cancer.
authors.affiliation: Nanjing Medical University Affiliated to Wuxi Second Hospital, Wuxi, Jiangsu, China.
authors.forename: Y
authors.initials: Y
authors.lastname: Ji
authors.affiliation: Nanjing Medical University Affiliated to Wuxi Second Hospital, Wuxi, Jiangsu, China.
authors.forename: H H
authors.initials: HH
authors.lastname: Jin
authors.affiliation: Nanjing Medical University Affiliated to Wuxi Second Hospital, Wuxi, Jiangsu, China.
authors.forename: M D
authors.initials: MD
authors.lastname: Wang
authors.affiliation: Nanjing Medical University Affiliated to Wuxi Second Hospital, Wuxi, Jiangsu, China.
authors.forename: W X
authors.initials: WX
authors.lastname: Cao
authors.affiliation: Nanjing Medical University Affiliated to Wuxi Second Hospital, Wuxi, Jiangsu, China.
authors.forename: J L
authors.initials: JL
authors.lastname: Bao